Abstract

BackgroundHIV-1 infects human astrocytes in vitro and in vivo but the frequency of infected cells is low and its biological significance is unknown. In studies in vitro, recombinant gp120 alone can induce profound effects on astrocyte biology, suggesting that HIV-1 interaction with astrocytes and its functional consequences extend beyond the limited levels of infection in these cells. Here we determined the relative efficiencies of HIV-1 binding and infection in human fetal astrocytes (HFA), mainly at the single cell level, using HIV-1 tagged with green fluorescence protein (GFP)-Vpr fusion proteins, termed HIV-GFP, to detect virus binding and HIV-1 expressing Rev and NefGFP fusion proteins to detect productive infection.ResultsEssentially all HFA in a population bound HIV-GFP specifically and independently of CCR5 and CXCR4. The dynamics of this binding at 37°C resembled binding of an HIV fusion mutant to CD4-positive cells, indicating that most of HIV-GFP arrested infection of HFA at the stage of virus-cell fusion. Despite extensive binding, only about 1% of HFA were detectably infected by HIV-RevGFP or HIV-NefGFP, but this proportion increased to the majority of HFA when the viruses were pseudotyped with vesicular stomatitis virus envelope glycoprotein G, confirming that HFA impose a restriction upon HIV-1 entry. Exposure of HFA to HIV-1 through its native proteins rapidly induced synthesis of interleukin-6 and interleukin-8 with increased mRNA detected within 3 h and increased protein detected within 18 h of exposure.ConclusionOur results indicate that HIV-1 binding to human astrocytes, although extensive, is not generally followed by virus entry and replication. Astrocytes respond to HIV-1 binding by rapidly increased cytokine production suggesting a role of this virus-brain cell interaction in HIV-1 neuropathogenesis.

Highlights

  • Human immunodeficiency virus type 1 (HIV-1) infects human astrocytes in vitro and in vivo but the frequency of infected cells is low and its biological significance is unknown

  • Using an approach developed by McDonald and colleagues [72], we prepared fluorescently-labeled infectious virions by co-transfection of plasmids encoding intact HIV-1/NL4-3 and a green fluorescence protein (GFP)-Vpr fusion protein that is efficiently encapsidated [72] and evaluated this HIV-GFP binding to human fetal astrocytes (HFA) by fluorescence microscopy

  • HeLa cells failed to bind HIV-1 but MAGI cells bound virus and this inhibition was sensitive to competition by soluble CD4 (sCD4), indicating that the evaluation of GFP-Vpr-labeled virus binding by microscopy is reliable

Read more

Summary

Introduction

HIV-1 infects human astrocytes in vitro and in vivo but the frequency of infected cells is low and its biological significance is unknown. There is evidence of HIV-1 infection in a small and variable fraction of astrocytes in vivo, in advanced brain disease [7,26,27,28,29,30] The significance of these overt astroglial pathologies is unknown but overall, unlike neurons, astrocytes rarely die in HIV-1-infected brains [31,32]. Productive infection of human astrocytes with HIV-1 has significant effects on cell physiology in vitro [33,34] and it associates with measurable neuropathology in a mouse model [35], suggesting that infected astrocytes, infrequent, can have localized pathogenic effects

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.